Nicolas Alexander Buchmann, PhD
Chief Technology Officer (CTO)
Resyca
Partnership Award Finalist
Next-Generation Pre-Filled Syringe Soft Mist Inhaler: Exploring Potential and Benefits for Delivering Sensitive Biologics and mRNA Vaccines via the Intranasal Route
Nicolas Buchmann is Chief Technology Officer at Resyca and holds a PhD in biomedical engineering and is a certified senior project manager. He has experience in developing oral and nasal inhalation drug delivery devices and in managing complex programs
and portfolios for inhalation drug-device combination products.